Home Finance Do you have $200? 2 Dividend Stocks to Buy and Hold Forever

Do you have $200? 2 Dividend Stocks to Buy and Hold Forever

by trpliquidation
0 comment
Do you have $200? 2 Dividend Stocks to Buy and Hold Forever

Medicine is the cornerstone of healthcare. That remains the case today, with the global pharmaceutical industry valued at $1.4 trillion and expected to grow at 6.1% per year until 2030. In light of this, it’s hard to see the sector going anywhere, meaning the companies that dominate the sector will remain great stocks for a long time to come. term investor can consider.

You don’t even need a lot of money to get started. Pfizer (NYSE:PFE) And Johnson & Johnson (NYSE: JNJ) are stalwarts in the sector with long track records, generous dividends and solid growth prospects. Moreover, their attractive valuations ensure that they buy on time.

If you have $200 (or more) available to invest in stocks, consider buying a share of each and holding them for the long term. This is why.

Pfizer’s rich history dates back to the mid-19th century. Although the company’s products have changed through innovation and mergers, it remains one of the leading pharmaceutical companies. Most recently, Pfizer was known for its COVID-19 vaccine (Comirnaty) and treatment (Paxlovid), which together generated $56.7 billion in sales at their peak in 2022. That business has largely dried up as COVID-19 cases surge has declined, and the resulting declines at both the top and bottom line levels have sent the stock to its lowest price level in a decade.

However, Pfizer is moving forward and reinventing itself, a key skill for any company looking to survive in the pharmaceutical industry. The company has determined its future growth on its oncology pipeline, which includes an influx of high-potential drugs following the $43 billion acquisition of Seagen in 2023. Sales and profits bottomed out and started growing again in 2024, paving the way for a nice future. Analysts expect Pfizer to grow profits at an average annual rate of 14% over the next three to five years.

Investors get a stake in Pfizer that has proven its ability to evolve to stay relevant. It also offers a dividend that yields 6.3% today, backed by a strong one payout ratio (57% of revenue). The stock could generate double-digit total investment returns well into the future, especially if the stock is valued at less than ten times forward earnings estimates.

Johnson & Johnson is another healthcare old-timer, dating back to the late 1800s. While it is essentially a pharmaceutical company, it is more diversified, with a vast MedTech segment that sells medical devices and other products. In August 2023, the company spun off its consumer products business Kenvue. Johnson & Johnson’s dividend is its claim to fame among investors. It is a Dividend King with 62 consecutive annual dividend increases.

You may also like

logo

Stay informed with our comprehensive general news site, covering breaking news, politics, entertainment, technology, and more. Get timely updates, in-depth analysis, and insightful articles to keep you engaged and knowledgeable about the world’s latest events.

Subscribe

Subscribe my Newsletter for new blog posts, tips & new photos. Let's stay updated!

© 2024 – All Right Reserved.